Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-075979
Filing Date
2025-05-21
Accepted
2025-05-21 20:08:34
Documents
1
Period of Report
2025-05-19

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3776
  Complete submission text file 0000950170-25-075979.txt   5434
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Issuer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 455 MISSION BAY BOULEVARD SOUTH C/O NEKTAR THERAPEUTICS SAN FRANCISCO CA 94158
Business Address
Zalevsky Jonathan (Reporting) CIK: 0001789857 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-24006 | Film No.: 25974503